Xiaodong Li
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 21
- Hepatitis C virus research 20
-
- MicroRNA in disease regulation 7
Xiaodong Li
140 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 151
- Hepatology 354
- Cancer Research 425
- Endocrine and Autonomic Systems 168
- Molecular Biology 1.7k
- Cardiology and Cardiovascular Medicine 535
Countries citing papers authored by Xiaodong Li
This map shows the geographic impact of Xiaodong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Li more than expected).
Fields of papers citing papers by Xiaodong Li
This network shows the impact of papers produced by Xiaodong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Li. The network helps show where Xiaodong Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaodong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 52 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 46 | |
| 13 | 2019 | 125 | |
| 14 | Identification of a novel entecavir-resistant mutation rtL180M+A186T+M204V of hepatitis B virus | 2019 | 1 |
| 15 | 2015 | 46 | |
| 16 | 2012 | 46 | |
| 17 | 2012 | 32 | |
| 18 | Tentative establishment of an acquisition platform of HBV sequence and drug resistance information | 2010 | 1 |
| 19 | No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation. | 2007 | 8 |
| 20 | 2006 | 168 |
About Xiaodong Li
Xiaodong Li is a scholar working on Hepatology, Cancer Research, Cardiology and Cardiovascular Medicine, Molecular Biology and Cell Biology, having authored 147 papers that have together received 3.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (9 papers), MicroRNA in disease regulation (7 papers), Kruppel-like factors research (6 papers), HIV/AIDS drug development and treatment (6 papers), Cardiac electrophysiology and arrhythmias (6 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Hepatology (354 citations), Cancer Research (425 citations), Endocrine and Autonomic Systems (168 citations), Molecular Biology (1.7k citations) and Cardiology and Cardiovascular Medicine (535 citations). Xiaodong Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chuo Chen, Stuart L. Schreiber, Feng Li, Pingjin Gao, Ju Chen, Jimo Borjigin, Solomon H. Snyder, Rahul Sanawar, Rakesh Kumar and Dingliang Zhu. Their work appears in journals such as Antiviral Therapy, PLoS ONE, Antiviral Research, Hypertension and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.